Figures computed from official regulatory filings — .
Analysttarget 24 USD (+570%) · consensus 4.43/5 · 5 buy · 2 hold · 0 sell
Ownershipinsiders 2.65% · institutions 111.8% · short 55.7% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for LENZ Therapeutics, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
LENZ Therapeutics, Inc. operates as a commercial pharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidates include VIZZ and LNZ101 for the treatment of presbyopia in adults. LENZ Therapeutics, Inc. was formerly known as Presbyopia Therapies, Inc. and changed its name to LENZ Therapeutics, Inc. in June 2021. The company was founded in 2013 and is headquartered in Solana Beach, California.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
10 buys36 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Scheiner Zachary | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Thunen Shelley B | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| George Jeffrey P. | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Guerard Frederic | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Drapkin Kimberlee C | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| MCCOLLUM JAMES W | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| RA CAPITAL MANAGEMENT, LLCtrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Schimmelpennink Evert B. | Buy | $251.4K | conv 86ClusterFirst in 12mo | SEC |
| George Jeffrey P. | Buy | $49.9K | conv 87ClusterFirst in 12mo | SEC |
| Chevallard Daniel R.track record | Buy | $64.3K | conv 80Cluster | SEC |
| Schimmelpennink Evert B. | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Chevallard Daniel R.track record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Odrich Marc | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Odrich Marc | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Olsson Shawn | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Chevallard Daniel R.track record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Olsson Shawn | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Olsson Shawn | Sell | $152.6K | SEC |
| Olsson Shawn | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Olsson Shawn | Exercise | $20.8K | Unusual size | SEC |
| Olsson Shawn | Sell | $108.4K | SEC |
| MCCOLLUM JAMES W | Buy | $239.3K | conv 81First in 12mo | SEC |
| Chevallard Daniel R.track record | Buy | $454.2 | conv 70First in 12mo | SEC |
| Chevallard Daniel R.track record | Buy | $49.6K | conv 92First in 12mo | SEC |
| Versant Vantage II GP-GP, LLC | Sell | $1.6M | SEC |